Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

Thomas Engstrøm(Rigshospitalet), Henning Kelbæk(University of Copenhagen), Steffen Helqvist(Rigshospitalet), Dan Eik Høfsten(Rigshospitalet), Lene Kløvgaard(Rigshospitalet), Lene Holmvang(Rigshospitalet), Erik Jørgensen(University of Copenhagen), Frants Pedersen(University of Copenhagen), Kari Saunamäki(University of Copenhagen), Peter Clemmensen(Rigshospitalet), Ole De Backer(University of Copenhagen), Jan Ravkilde(Aalborg University Hospital), Hans–Henrik Tilsted(Aalborg University Hospital), Anton Boel Villadsen(Aalborg University Hospital), Jens Aarøe(Aalborg University Hospital), Svend Eggert Jensen(Aalborg University Hospital), Bent Raungaard(Aalborg University Hospital), Lars Køber(University of Copenhagen)
The Lancet
August 1, 2015
Cited by 962

Abstract


Related Papers

No related papers found

Powered by citation graph analysis